Filter
|
|
|
|
|
|
GSE162338
|
|
|
|
GSM4911338
|
ETV6-NCOA2 CD34
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4911339
|
ETV6-NCOA2 CD34_control
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4911340
|
Empty vector CD34
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4911341
|
Empty vector CD34_control
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4911342
|
ETV6-NCOA2 patient-derived xenograft
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4911343
|
ETV6-NCOA2 patient-derived xenograft_control
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912892
|
ETV6-NCOA2 patient derived xenograft_1 [EN2_PDX_3]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912893
|
ETV6-NCOA2 patient derived xenograft_2 [EN2_PDX_1]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912894
|
ETV6-NCOA2 patient derived xenograft_3 [EN2_PDX_2]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912895
|
ETV6-NCOA2+NOTCH1-L1601PdP_1 [EN2+N_5]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912896
|
ETV6-NCOA2+NOTCH1-L1601PdP_2 [EN2+N_4]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912897
|
ETV6-NCOA2+NOTCH1-L1601PdP_3 [EN2+N_3]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912898
|
ETV6-NCOA2+NOTCH1-L1601PdP_4 [EN2+N_1]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912899
|
ETV6-NCOA2+NOTCH1-L1601PdP_5 [EN2+N_2]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912900
|
ETV6-NCOA2_1 [EN2_2]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912901
|
ETV6-NCOA2_2 [EN2_3]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912902
|
ETV6-NCOA2_3 [EN2_1]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912903
|
ETV6-NCOA2_in-vitro_1 [EN2_in_vitro_1]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912904
|
ETV6-NCOA2_in-vitro_2 [EN2_in_vitro_2]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|
GSM4912905
|
ETV6-NCOA2_in-vitro_3 [EN2_in_vitro_3]
|
SRA
|
|
1 |
|
|
|
Gilgi Friedlander
|
May 16, 2022
|